Tocilizumab or TNF inhibitors in RA?

被引:3
|
作者
Leake I. [1 ]
机构
[1] Nature Reviews Rheumatology,
关键词
D O I
10.1038/s41584-018-0031-7
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:384 / 384
相关论文
共 50 条
  • [1] Glucocorticoid sparing effect of TNF inhibitors in RA
    Buch, Maya
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 829 - 829
  • [2] Are TNF inhibitors still the agent of choice for RA?
    Peter C. Taylor
    Nature Reviews Rheumatology, 2023, 19 : 755 - 756
  • [3] Are TNF inhibitors still the agent of choice for RA?
    Taylor, Peter C.
    NATURE REVIEWS RHEUMATOLOGY, 2023,
  • [4] Are TNF inhibitors still the agent of choice for RA?
    Taylor, Peter C.
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (12) : 755 - 756
  • [5] TNF inhibitors and cardiovascular risk management in RA
    Janet E. Pope
    Nature Reviews Rheumatology, 2016, 12 : 317 - 318
  • [6] Risk for Lower Intestinal Perforations in RA Patients Treated with Tocilizumab in Comparison to Treatment with TNF Inhibitors, Rituximab, Abatacept or Conventional Synthetic Dmards
    Strangfeld, Anja
    Richter, Adrian
    Herzer, Peter
    Rockwitz, Karin
    Demary, Winfried
    Aringer, Martin
    Zink, Angela
    Listing, Joachim
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] Serious Infections in RA Offspring Exposed to TNF Inhibitors
    Vinet, Evelyne
    Moura, Cristiano
    Pineau, Christian
    Abrahamowicz, Michal
    Curtis, Jeffrey
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 893 - 894
  • [8] Demyelinating Disorders in RA Offspring Exposed to TNF Inhibitors
    Vinet, Evelyne
    Scott, Susan
    Moura, Cristiano
    Pineau, Christian
    Curtis, Jeffrey
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1057 - 1057